VTA releases its Next Level Analysis on the Deeming Regulation
What the US should learn from the UK’s wisdom on e-cigarettes – Sally Satel
This is one of the better articles to come out recently discussing the data needed to submit for approval through the PMTA pathway the FDA has laid out in the current deeming regs. Very much worth the read.
From the article….
“…Added to this onus is the so-called “public health or population impact.” According to the FDA, “Manufacturers must, for each product, quantify the likelihood that nonsmokers will start using the product, the likelihood that former smokers will relapse back to nicotine use by using the product, the likelihood that nonsmokers who do start using the product will progress to cigarette smoking, the likelihood that former smokers who relapse back to nicotine use will then progress to smoking, the likelihood that consumers will use the product in conjunction with other tobacco products, and the likelihood that smokers who start using the product would otherwise have quit smoking.”
Vapor Technology releases comments on FDA deeming regulations.
Late last night Tony Abboud, National Legislative Director for the VTA, released the following statements and initial thoughts the FDA Deeming Regulations released 5/5/16. Please follow the ink below to read the full document.
The GSFA fully supports the VTA and their course of action. Stay tuned for additional releases.
We are also encouraging shop owners and employees to print out the document to share with your customers. Consumers will be coming into your shops with questions. We owe it to them to give them good advice and pint them in the right direction.
Link to VTA press release.